JWH-200

JWH-200 is a synthetic cannabinoid that has been used in research for many years. This comprehensive guide will give you all the information that you need about JWH 200, including its chemical properties, development, uses, effects and recommended dosage.

Development and Background

JWH-200, a synthetic cannabinoid, is part of the JWH series, developed by John W. Huffman. Huffman is a professor and renowned chemist at Clemson. Huffman synthesized these compounds as part of his research to develop novel cannabinoid agonists that could have therapeutic applications. JWH-200 is not approved for medical or human use. However, its pharmacological properties have attracted the attention of researchers.

Chemical Name and CAS Number

JWH-200’s CAS number is 61929447-2. This is used as a unique identifier in scientific databases. The IUPAC (International Union of Pure and Applied Chemistry) name for JWH-200 is (2-(2-morpholin-4-yl-1H-indol-3-yl)-1-naphthalenyl)methanone. This name provides researchers with a standard reference and describes the chemical structure of the compound.

Molecular Formula

The molecular formula of JWH-200 is C23H22N2O2, which means that it contains two nitrogen atoms and two oxygen molecules. Its molecular mass is 358.44 grams/mol.

Shape and color of the compound

JWH-200 is typically a powdery white or off-white color. Its crystalline structure makes it easy to work with and handle during research. JWH-200 must be stored in a dry, cool place away from direct sunlight and heat to maintain its integrity.

JWH-200: Uses and effects

JWH-200 is not approved for human consumption, nor medical use. However, it has been used in scientific research as a potent cannabinoid agonist, especially at CB1 receptors and CB2 receptors. These receptors are essential in many physiological processes such as the regulation of pain, immune system function and mood regulation. JWH-200 is being studied by researchers to better understand the endocannabinoid systems and potential therapeutic benefits from synthetic cannabinoids.

JWH-200 has a high affinity and selectivity towards the CB1 CB1 receptor which is primarily found in the brain. The compound mimics the effects of cannabinoids such as THC. These effects can include feelings of euphoria and relaxation, altered perceptions, and an increased appetite. JWH-200, however, is more potent than THC. This means that it has a greater impact and more adverse side effects.

Dosage and precautions

JWH-200, a research chemistry that has not been approved by the FDA for human consumption is extremely dangerous. It must be handled with extreme care. Researchers who work with JWH-200 must adhere to strict safety protocol, including using personal protective equipment (PPE) and implementing proper ventilation.

In vitro and in vivo, dosages of JWH 200 should be determined carefully based on study objectives and conditions. When designing experiments, researchers must also consider the compound’s potency as well as its potential for adverse effects.

JWH-200 has a lot of research potential. Researchers who want to understand endocannabinoids will find JWH-200 an ideal candidate because of its unique chemical structure, pharmacological profiles, and ease in handling.